Most cited papers from PaxVax (United States)

PaxVax (United States)

What are the most cited papers from PaxVax (United States)?

The most cited paper from PaxVax (United States) is "Yellow fever" (Thomas P. C. Monath, Pedro Fernando da Costa Vasconcelos, 2014), with 688 citations. Next come "Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus" (219) and "Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor" (209).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 58 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Yellow fever Thomas P. C. Monath, Pedro Fernando da Costa Vasconcelos · Journal of Clinical Virology Open access	24 Oct 2014	688
2	Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus Kathryn A. Hanley, Thomas P. C. Monath, Scott C. Weaver et al. · Infection Genetics and Evolution Open access	20 Mar 2013	219
3	Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8 Receptor Katherine Basore, Arthur S. Kim, Christopher A. Nelson et al. · Cell Open access	9 May 2019	209
4	Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor Wilbur H. Chen, Mitchell B. Cohen, Beth D. Kirkpatrick et al. · Clinical Infectious Diseases Open access	21 Mar 2016	201
5	Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family Donald B. Smith, Paul Becher, Jens Bukh et al. · Journal of General Virology Open access	30 Sep 2016	177
6	Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study Marc Gurwith, Michael D. Lock, Eve M. Taylor et al. · The Lancet Infectious Diseases Open access	28 Jan 2013	156
7	Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV‐1 gp120 Vaccine Peter B. Gilbert, Maggie Haitian Wang, Terri Wrin et al. · The Journal of Infectious Diseases Open access	7 Jul 2010	130
8	Vaccines against diseases transmitted from animals to humans: A one health paradigm Thomas P. C. Monath · Vaccine Open access	21 Sep 2013	127
9	Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults Jeffrey S. Kennedy, Marc Gurwith, C. L. Dekker et al. · The Journal of Infectious Diseases Open access	15 Sep 2011	107
10	Estimating cholera incidence with cross-sectional serology Andrew S. Azman, Justin Lessler, Francisco Javier Luquero et al. · Science Translational Medicine Open access	20 Feb 2019	75
11	Age, Race/Ethnicity, and Behavioral Risk Factors Associated With Per Contact Risk of HIV Infection Among Men Who Have Sex With Men in the United States Hyman M Scott, Eric Vittinghoff, Risha Irvin et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes Open access	5 Sep 2013	74
12	PaxVax CVD 103-HgR single-dose live oral cholera vaccine Myron M. Levine, Wilbur H. Chen, James B. Kaper et al. · Expert Review of Vaccines Open access	6 Feb 2017	67
13	Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin Jeff Alexander, Simone Visosky Ward, Jason Mendy et al. · PLoS ONE Open access	17 Feb 2012	64
14	Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge Diego A. Espinosa, Jason Mendy, Darly Joseph Manayani et al. · EBioMedicine Open access	12 Dec 2017	60
15	INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies Baoling Ying, Károly Tóth, Jacqueline F. Spencer et al. · Cancer Gene Therapy Open access	6 Feb 2009	60
16	Protein nanovaccine confers robust immunity against Toxoplasma Kamal El Bissati, Ying Zhou, Sara M. Paulillo et al. · npj Vaccines Open access	15 Aug 2017	59
17	Safety and Immunogenicity of Single-Dose Live Oral Cholera Vaccine Strain CVD 103-HgR, Prepared from New Master and Working Cell Banks Wilbur H. Chen, Richard Neil Greenberg, Marcela F. Pasetti et al. · Clinical and Vaccine Immunology Open access	30 Oct 2013	50
18	Adjuvanted multi-epitope vaccines protect HLA-A11:01 transgenic mice against Toxoplasma gondii Kamal El Bissati et al. · JCI Insight* Open access	21 Sep 2016	48
19	Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains RICHARD C. CONDIT, Anna‐Lise Williamson, Rebecca Sheets et al. · Vaccine Open access	25 Jun 2016	48
20	Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers Kamrul Islam et al. · PLoS neglected tropical diseases Open access	6 Apr 2018	37
21	Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population Douglas J. Haney, Michael D. Lock, Jakub K. Simon et al. · Clinical and Vaccine Immunology Open access	Jun 2017	36
22	The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) Robert T. Chen, Baevin Carbery, Lisa Marie Mac et al. · Vaccine Open access	9 Oct 2014	36
23	Pilot-scale chitin extraction from shrimp shell waste by deproteination and decalcification with bacterial enrichment cultures Mini Bajaj, Andrea Freiberg, Josef U. Winter et al. · Applied Microbiology and Biotechnology	30 Jul 2015	36
24	Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection Rosie T. Jiang, Joshua W. Wang, Shiwen Peng et al. · Journal of Virology Open access	18 May 2017	34
25	Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus Lo Vang, Christopher S. Morello, Jason Mendy et al. · PLoS neglected tropical diseases Open access	12 Mar 2021	29
26	A Multivalent Vaccination Strategy for the Prevention of Old World Arenavirus Infection in Humans Jason Botten, J. Lindsay Whitton, Polly Barrowman et al. · Journal of Virology Open access	29 Jul 2010	29
27	Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C Jeff Alexander, Jason Mendy, Lo Vang et al. · PLoS ONE Open access	3 Dec 2013	29
28	Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection Douglas J. Haney, Michael D. Lock, Marc Gurwith et al. · Vaccine Open access	11 Apr 2018	28
29	Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis Bettina Klug, James S. Robertson, RICHARD C. CONDIT et al. · Vaccine Open access	15 Jun 2016	27
30	Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge Delphine C. Malherbe et al. · Journal of Virology Open access	Nov 2017	24
31	Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization Surender Khurana, Elizabeth M. Coyle, Jody F. Manischewitz et al. · PLoS ONE Open access	28 Jan 2015	24
32	Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines Sonali Kochhar, Jean‐Louis Excler, Karin Bok et al. · Vaccine Open access	26 Nov 2018	21
33	Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18–45 James M McCarty, Michael D. Lock, Kristin M. Hunt et al. · Vaccine Open access	6 Jan 2018	21
34	The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae Leslie M. Mayo-Smith, Jakub K. Simon, Wilbur H. Chen et al. · Clinical and Vaccine Immunology Open access	10 Nov 2016	20
35	Real-Time Model Predictive Control for Industrial Manipulators with Singularity-Tolerant Hierarchical Task Control Jaemin Lee, Mingyo Seo, Andrew Bylard et al. Conference paper	29 May 2023	19
36	Gut-Homing Conventional Plasmablasts and CD27− Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans Franklin R. Toapanta, Jakub K. Simon, Eileen M. Barry et al. · Frontiers in Immunology Open access	20 Aug 2014	19
37	Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba Motaher Hossain et al. · PLoS neglected tropical diseases Open access	19 Nov 2019	14
38	Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial James M McCarty, Michael D. Lock, Sean R. Bennett et al. · Vaccine Open access	13 Feb 2019	12
39	Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator Samba Ousmane Sow et al. · Clinical and Vaccine Immunology Open access	12 Oct 2017	12
40	Purification of Adenovirus Paul W. Shabram, Gary Vellekamp, Qian Ruan et al. · Elsevier eBooks Book chapter	2016	12
41	A manifesto for planetary health Laura H. Kahn, Bruce E. Kaplan, Thomas P. C. Monath et al. · The Lancet	Apr 2014	12
42	Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccines Svenja Weiß, Vincenza Itri, Ruimin Pan et al. · Nature Communications Open access	16 Feb 2022	11
43	Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children and Adolescents Aged 6–17 Years James M McCarty, Emma C. Gierman, Lisa Bedell et al. · American Journal of Tropical Medicine and Hygiene Open access	26 Nov 2019	11
44	Attenuation of Replication-Competent Adenovirus Serotype 26 Vaccines by Vectorization Lori F. Maxfield, Peter Abbink, Kathryn E. Stephenson et al. · Clinical and Vaccine Immunology Open access	17 Sep 2015	10
45	Reasons Women Experiencing Intimate Partner Violence Seek Assistance From Employee Assistance Programs Keshia M. Pollack, Christopher Cummiskey, Karol P. Krotki et al. · Journal of Workplace Behavioral Health	4 Aug 2010	10
46	Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge Danielle Thompson, Ben Guenther, Darly Joseph Manayani et al. · PLoS neglected tropical diseases Open access	6 Jul 2022	9
47	Full Genomic Sequence of the Prototype Strain (M64) of Rio Bravo Virus Evgeniya Volkova, Robert B. Tesh, Thomas P. C. Monath et al. · Journal of Virology Open access	28 Mar 2012	7
48	Learning from marketing: Rapid development of medication messages that engage patients Veronica A. Yank, Erika Lauren Tribett, Lydia Green et al. · Patient Education and Counseling Open access	14 Mar 2015	3
49	CD4+ T Cell Responses to Toxoplasma gondii Are a Double-Edged Sword Kamal El Bissati, Paulette A. Krishack, Ying Zhou et al. · Vaccines Open access	14 Sep 2023	2
50	Differential V2-directed Antibody Responses in Non-human Primates Infected with SHIVs or Immunized with Diverse HIV Vaccines Susan Zolla‐Pazner, Svenja Weiß, Vincenza Itri et al. · Research Square PreprintOpen access	5 Oct 2021	1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.